Speaker illustration

Doctor Syed Khurram Mushtaq Gardezi

Royal Brompton Hospital Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)

Member of:

European Society of Cardiology
Heart Failure Association

Dr Gardezi is a Senior registrar in Cardiology working in Heart failure and CMR at the Royal Brompton Hospital Imperial College London. Dr Gardezi has successfully completed his research fellowship from University of Oxford leading to MSc by Research. His research involved the clinical epidemiology of atrial fibrillation, the role of serum biomarkers in identifying atrial fibrillation and the relationship of atrial fibrillation with heart valve disease. Dr Gardezi has also worked as SpR in Advanced Heart Failure, Transplant & Mechanical circulatory support, Heart failure & inherited cardiac conditions and Adult congenital heart disease & Pulmonary hypertension at Royal Brompton & Harefield Hospitals & Guys and St Thomas' Hospital NHS Foundation Trusts London previously. Dr Gardezi is a member of ESC, EACVI, BCS, BSH, BHVS, RCP(London), RCPSG (Glasgow) RCP(Ireland) & the Academy of Medical Educators UK.

Oral anticoagulation in patients with atrial fibrillation: the contemporary trends in primary care

Event: EuroEcho-Imaging 2018

Topic: Cross-Modality and Multi-Modality Imaging Topics, Other

Session: Imaging - Other

Thumbnail

The predictors and risk factors of atrial fibrillation in a population cohort and its association with valvular heart disease

Event: ESC Congress 2018

Topic: Clinical, Other

Session: Thrombosis and antithrombotic treatment in valvular heart disease

Thumbnail

The prevalence of atrial fibrillation in a population cohort and its association with valvular heart disease

Event: EuroEcho-Imaging 2017

Topic: Valvular heart disease associated with systemic conditions

Session: Heart valves

Thumbnail

Cardiac auscultation in diagnosing valvular heart disease: a comparison between general practitioners and cardiologists

Event: ESC CONGRESS 2017

Topic: Valvular heart disease, other

Session: Decision making in complex valvular disease

Thumbnail

This platform is supported by

logo Novo Nordisk